Clinical study updateUPPSALA, Sweden, Jan. 9, 2026 /PRNewswire/ -- Synartro is advancing the candidate drug SYN321, a novel intra-articular treatment for knee osteoarthritis, through a phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback